Hims & Hers Acquires Zava: Telehealth Expansion
- Hims & Hers Health (HIMS) is set to acquire Wonders, a European telehealth platform, in a move to considerably expand its global presence.
- The deal, expected to close by mid-year, will see Hims & Hers absorb Wonders' 1.3 million active customers, increasing its subscriber base by approximately 50%.
- Dudum had previously highlighted the company's commitment to global expansion during an earnings call in May, noting the early success in the United Kingdom.
Hims & Hers Acquires Wonders for European Telehealth Expansion
Updated June 4, 2025
Hims & Hers Health (HIMS) is set to acquire Wonders, a European telehealth platform, in a move to considerably expand its global presence. CEO Andrew Dudum announced the acquisition, emphasizing its role in accelerating European expansion and facilitating entry into new markets.
The deal, expected to close by mid-year, will see Hims & Hers absorb Wonders’ 1.3 million active customers, increasing its subscriber base by approximately 50%. Currently, Hims & Hers has 2.4 million subscribers.
Dudum had previously highlighted the company’s commitment to global expansion during an earnings call in May, noting the early success in the United Kingdom. Hims & Hers initially expanded to the U.K. in 2021 with the acquisition of Honest Health.
With the acquisition of Wonders,Hims & Hers will extend its services to Ireland,France,and Germany. Wonders CEO David Meinertz, who founded the platform in 2011, believes the deal will alleviate pressure on the European health-care system.
Meinertz noted the affordability of medications through telehealth, stating, “The medications are priced more competitively than in the U.S. so more people can actually afford it and we are seeing a huge demand.”
Following the acquisition, the Wonders platforms will retain their branding for a few quarters before transitioning to the Hims & Hers brand. Meinertz will then assume the role of general manager of the international business.
Dudum expressed confidence in the company’s growth strategy, citing the advantageous pharmaceutical pricing in Europe compared to the United States. He believes this will make accessible,personalized treatments easier to deliver overseas.
What’s next
Hims & Hers plans to integrate the Wonders platform and expand its service offerings in Europe, leveraging the established customer base and infrastructure to further penetrate the European telehealth market.